AstraZeneca Pharma Quarterly Results for Trading Insights
ASTRAZEN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹116 Cr
QMarch 2025
AstraZeneca Pharma Quarterly Results Key Highlights
- Revenue of ₹1,757 Cr in March 2025 (+0.0% vs March 2025, +32.1% vs March 2024)
- Net Profit of ₹116 Cr in March 2025 (+0.0% vs March 2025, -28.4% vs March 2024)
- EBITDA of ₹295 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 15.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹46.30 in March 2025 (+0.0% vs March 2025)
AstraZeneca Pharma Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,218 | 1,757 | 1,330 | 1,029 | 820 | 26.2% | - |
| Net Profit (₹ Cr) | 201 | 116 | 162 | 99 | 62 | - | - |
| EBITDA (₹ Cr) | 316 | 295 | 219 | 191 | 101 | - | - |
| EPS (₹) | 80.40 | 46.30 | 64.60 | 39.70 | 24.60 | - | - |
| Operating Margin (%) | 13.0% | 15.0% | 14.0% | 16.0% | 11.0% | - | - |
AstraZeneca Pharma Share Price Trend Around Quarterly Results
Visualize AstraZeneca Pharma's 1-year price movement across quarterly results — ideal for logging trades in AstraZeneca Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for AstraZeneca Pharma
Additional stock information and data for ASTRAZEN
Revenue Trend (₹ Cr)
March 2023
1,029
March 2024
1,330
March 2025
1,757
2026
2,218
Net Profit Trend (₹ Cr)
March 2023
99
March 2024
162
March 2025
116
2026
201
Operating Margin Trend (%)
March 2023
16.0%
March 2024
14.0%
March 2025
15.0%
2026
13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing AstraZeneca Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹429,456.97 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,416.93 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores